Literature DB >> 1881329

Gadolinium-labeled liposomes containing various amphiphilic Gd-DTPA derivatives: targeted MRI contrast enhancement agents for the liver.

G W Kabalka1, M A Davis, T H Moss, E Buonocore, K Hubner, E Holmberg, K Maruyama, L Huang.   

Abstract

Unique paramagnetic liposomal contrast agents were synthesized and utilized for selective augmentation of T1 MR imaging of the livers of normal Balb/c mice. A series of amphipathic gadolinium complexes, which mimic phospholipids, was incorporated into the lamella of small unilamellar liposomes such that they become an integral part of its surface. The amphipathic complexing agents consisted of DTPA reagents in which two stearyl chains are attached via amide, ester, and thioester linkages. The in vitro stability and the in vivo lifetimes of the new amphipathic agents were dependent on the method used to attach the long-chain alkyl groups.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1881329     DOI: 10.1002/mrm.1910190231

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  18 in total

Review 1.  Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics.

Authors:  Aaron Joseph L Villaraza; Ambika Bumb; Martin W Brechbiel
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

2.  A cell-permeable gadolinium contrast agent for magnetic resonance imaging of copper in a Menkes disease model.

Authors:  Emily L Que; Elizabeth J New; Christopher J Chang
Journal:  Chem Sci       Date:  2012-04-18       Impact factor: 9.825

3.  Paramagnetic liposomes containing amphiphilic bisamide derivatives of Gd-DTPA with aromatic side chain groups as possible contrast agents for magnetic resonance imaging.

Authors:  Tatjana N Parac-Vogt; Kristof Kimpe; Sophie Laurent; Corinne Piérart; Luce Vander Elst; Robert N Muller; Koen Binnemans
Journal:  Eur Biophys J       Date:  2005-10-11       Impact factor: 1.733

4.  Monitoring the intragastric distribution of a colloidal drug carrier model by magnetic resonance imaging460.

Authors:  H Faas; W Schwizer; C Feinle; H Lengsfeld; C de Smidt; P Boesiger; M Fried; T Rades
Journal:  Pharm Res       Date:  2001-04       Impact factor: 4.200

5.  Enhanced accumulation of long-circulating liposomes modified with the nucleosome-specific monoclonal antibody 2C5 in various tumours in mice: gamma-imaging studies.

Authors:  Tamer A Elbayoumi; Vladimir P Torchilin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-06-09       Impact factor: 9.236

Review 6.  Advances in gadolinium-based MRI contrast agent designs for monitoring biological processes in vivo.

Authors:  Jacques Lux; A Dean Sherry
Journal:  Curr Opin Chem Biol       Date:  2018-05-09       Impact factor: 8.822

Review 7.  Liposomes in drug delivery. Clinical, diagnostic and ophthalmic potential.

Authors:  G Gregoriadis; A T Florence
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546

Review 8.  Paramagnetic and fluorescent liposomes for target-specific imaging and therapy of tumor angiogenesis.

Authors:  Gustav J Strijkers; Ewelina Kluza; Geralda A F Van Tilborg; Daisy W J van der Schaft; Arjan W Griffioen; Willem J M Mulder; Klaas Nicolay
Journal:  Angiogenesis       Date:  2010-06       Impact factor: 9.596

9.  Biocompatible Polyhydroxyethylaspartamide-based Micelles with Gadolinium for MRI Contrast Agents.

Authors:  Sang Young Jeong; Hyo Jeong Kim; Byung-Kook Kwak; Ha-Young Lee; Hasoo Seong; Byung Cheol Shin; Soon Hong Yuk; Sung-Joo Hwang; Sun Hang Cho
Journal:  Nanoscale Res Lett       Date:  2010-09-02       Impact factor: 4.703

10.  Gadolinium-containing phosphatidylserine liposomes for molecular imaging of atherosclerosis.

Authors:  Andrei Maiseyeu; Georgeta Mihai; Thomas Kampfrath; Orlando P Simonetti; Chandan K Sen; Sashwati Roy; Sanjay Rajagopalan; Sampath Parthasarathy
Journal:  J Lipid Res       Date:  2008-11-17       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.